Tarsus Pharmaceuticals Inc banner

Tarsus Pharmaceuticals Inc
NASDAQ:TARS

Watchlist Manager
Tarsus Pharmaceuticals Inc Logo
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Watchlist
Price: 73.02 USD -1.97% Market Closed
Market Cap: $3.1B

Intrinsic Value

The intrinsic value of one TARS stock under the Base Case scenario is hidden USD. Compared to the current market price of 73.02 USD, Tarsus Pharmaceuticals Inc is hidden .

TARS Intrinsic Value
HIDDEN
Show

Valuation History
Tarsus Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

TARS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if TARS is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about TARS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TARS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tarsus Pharmaceuticals Inc.

Explain Valuation
Alternatives to TARS

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Tarsus Pharmaceuticals Inc

Wall St
Price Targets

Dividends

Tarsus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

TARS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TARS stock?

The intrinsic value of one TARS stock under the Base Case scenario is hidden USD.

Is TARS stock undervalued or overvalued?

Compared to the current market price of 73.02 USD, Tarsus Pharmaceuticals Inc is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett